A beloved company that has been part of the fabric of the US and has served hundreds of millions of customers around the ...
Shares of weight loss and diabetes medication maker Novo Nordisk (NYSE: NVO) have slumped precipitously over the past 52 ...
In a report released today, Jo Walton from UBS maintained a Buy rating on Novo Nordisk (0QIU – Research Report), with a price target of ...
Novo Nordisk reprimanded for allegedly failing to disclose payments - The manufacturer of the weight loss jab Wegovy said it ...
Six percent of Americans have used Ozempic, Wegovy and similar drugs. They’re unwitting experimental subjects.
While a smattering of media reports shows thieves are after Ozempic elsewhere in the world Brazil has become a prime global hot spot for criminals coveting the hugely popular weight-loss drugs.